Eye-Net showcased its V2X collision prevention technology at CES 2026, highlighting beyond line-of-sight safety for vehicles ...

The U.S. Food and Drug Administration (FDA) is preparing to fast-track reviews of two experimental Merck & Co. Inc. (NYSE: MRK) drugs with potential blockbuster sales. Merck's cholesterol treatment ...

COLORADO SPRINGS, Colo. — The North America Aerospace Defense Command (NORAD) is looking for volunteers to help track Santa on Christmas Eve. NORAD is recruiting 1,000 mostly volunteers to accept ...

CHICAGO (WLS) -- The afternoon commute on the CTA Yellow Line is back to normal, after a train derailment earlier Tuesday. The Yellow Line runs from Chicago's far North Side to suburban Skokie.

Justin Hartley as Colter Shaw standing outside next to Brent Sexton as John Keaton in Tracker Season 3 Image via CBS Editor's Note: The following contains spoilers for Tracker Season 3, Episode ...

Dec 9 (Reuters) - The U.S. Food and Drug Administration approved on Tuesday the first drug under its new fast-track program designed to shorten review time for a drug application. The approval for the ...

Construction of a 2-mile track in East Huntingdon to test autonomous vehicles and train first responders is underway, with the facility expected to be in operation by late 2026. The project’s first ...

It's Early Signing Day for Michigan football and the Wolverines are expected to sign most, if not all, of their 2026 class on Wednesday. Stay tuned to this page for instant updates once players start ...

It's Early Signing Day for Baylor football and the Bears are hoping to sign most, if not all, of their 2026 class on Wednesday. Stay tuned to this page for instant updates once players start to sign ...

Around 200 athletes were warming up one recent afternoon on the track behind Cuthbertson High School. It looked like a multi-team track and field meet was about to begin. Except this wasn’t a ...

Becoming a blockbuster in its third full year on the market put Gilead’s cancer treatment Trodelvy on a course to potentially justify the company’s $21 billion buyout of Immunomedics in 2020. But ...